BUZZ - HCA shares rise on better-than-expected Q3 earnings
路透社2026/10/27 11:34October 27 - ** Hospital operator HCA Healthcare (HCA.N) saw its stock price rise 4.8% in premarket trading, to $487.57
** According to LSEG data, HCA's adjusted earnings per share for the third quarter were $7.22, higher than the market expectation of $6.66
** The company reported third-quarter revenue of $19.85 billion, which was higher than analysts' expectations of $19.33 billion
** The company expects its full-year operating performance to be at the upper end of the 2026 forecast range previously released on July 15
** In July, HCA stated that it expected full-year adjusted earnings per share to range between $28.70 and $30.50
** As of the previous trading day's close, the stock has been roughly flat for the year
(To assist non-native English speakers, Reuters provides automated translations of its reports into several other languages. As automated translations may contain errors or fail to capture the desired context, Reuters does not guarantee the accuracy of these translations and provides them solely for the convenience of readers. Reuters is not liable for any damage or loss arising from the use of automated translation services.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AstraZeneca (AZN.US) CEO hints at entry into cancer vaccines: years of experience with mRNA technology and more updates expected in the coming months
AstraZeneca is considering developing a cancer vaccine, with the CEO stating that the company has already accumulated experience in mRNA technology. Personalized vaccines have reduced the recurrence rate of melanoma by 42%, but cost and production capacity remain obstacles to broader adoption.
SpaceX (SPCX.US) enters Bank of America's "US 1" preferred stock list as Wall Street renews its confidence in Musk's long-term space vision.
Bank of America Securities released a research report on Tuesday, adding SpaceX to its "US 1" list of preferred investment targets, signaling increased confidence in the outlook for the company led by Elon Musk.
Anthropic prospectus "stimulates greed"! CoreWeave leads AI trade rebound
Anthropic's IPO prospectus revealed a first-half revenue of 16.3 billions USD, representing a nearly 14-fold year-on-year surge, alleviating market concerns about the unsustainability of AI’s capital consumption. CoreWeave led a broad rebound in the AI infrastructure sector, rising 8% in a single day. Anthropic's long-term capital commitment to computing power directly confirms the demand outlook for new cloud service providers, storage, and optical connectivity infrastructure sectors.
Cash reserves far exceed almost all U.S. companies! Anthropic (ANT.US) holds $131.7 billion, accelerating towards IPO; cash may surpass $230 billion after fundraising
According to the latest documents, Anthropic's cash reserves have surpassed those of almost all companies in the United States.
Crypto prices
More
